DEC1 Produkte
(Deleted in Esophageal Cancer 1 (DEC1))
Kategorien
Candidate tumor supressor.
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte DEC1 Kategorien
DEC1 Antikörper
High quality antibodies with extensive validation data.
Empfohlene DEC1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IP, IHC (fp)
Validierungen
Kat. Nr.
ABIN7454653
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB
Validierungen
- (1)
Kat. Nr.
ABIN5027144
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IP
Validierungen
Kat. Nr.
ABIN2252137
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene DEC1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN3078882
Menge
1 mg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren DEC1 Produkten
: "Smad3 Suppresses Epithelial Cell Migration and Proliferation via the Clock Gene Dec1, Which Negatively Regulates the Expression of Clock Genes Dec2 and Per1." in: The American journal of pathology, Vol. 189, Issue 4, pp. 773-783, (2019) (PubMed).: "Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity." in: Nature immunology, Vol. 20, Issue 6, pp. 687-700, (2019) (PubMed).
: "Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions." in: PLoS ONE, Vol. 13, Issue 2, pp. e0192136, (2018) (PubMed).
: "Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus." in: PLoS ONE, Vol. 13, Issue 5, pp. e0196223, (2018) (PubMed).
: "Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection." in: The Journal of experimental medicine, Vol. 215, Issue 7, pp. 1823-1838, (2018) (PubMed).
: "DEC1 negatively regulates the expression of CXCL10 and CCL5 induced by poly IC in normal human mesangial cells." in: Biomedical research (Tokyo, Japan), Vol. 38, Issue 4, pp. 249-255, (2018) (PubMed).
: "DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells." in: Biomedical research (Tokyo, Japan), Vol. 38, Issue 4, pp. 221-227, (2018) (PubMed).
: "DEC2 expression antagonizes cisplatin‑induced apoptosis in human esophageal squamous cell carcinoma." in: Molecular medicine reports, Vol. 16, Issue 1, pp. 43-48, (2017) (PubMed).
: "Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α." in: Histochemistry and cell biology, Vol. 148, Issue 6, pp. 617-624, (2017) (PubMed).
: "IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation." in: The Journal of experimental medicine, Vol. 213, Issue 2, pp. 251-71, (2016) (PubMed).
Synonyme und alternative Namen zu DEC1
deleted in esophageal cancer 1 (DEC1), CTS9, DEC1Bezeichner auf Proteinebene für DEC1
- candidate tumor suppressor CTS9
- deleted in esophageal cancer 1
Sie sind hier:
